Your browser doesn't support javascript.
loading
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Cook, Gordon; Royle, Kara-Louise; O'Connor, Sheila; Cairns, David A; Ashcroft, A John; Williams, Cathy D; Hockaday, Anna; Cavenagh, Jamie D; Snowden, John A; Ademokun, Debo; Tholouli, Eleni; Andrews, Vivienne E; Jenner, Matthew; Parrish, Christopher; Yong, Kwee; Cavet, Jim; Hunter, Hannah; Bird, Jenny M; Pratt, Guy; Drayson, Mark T; Brown, Julia M; Morris, Treen C M.
Afiliação
  • Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Royle KL; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • O'Connor S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cairns DA; HMDS, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Ashcroft AJ; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Williams CD; Mid-Yorkshire NHS Trust, Wakefield, UK.
  • Hockaday A; Department of Haematology, Centre for Clinical Haematology, Nottingham City Hospitals, Nottingham, UK.
  • Cavenagh JD; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Snowden JA; Department of Haematology, Barts & The London NHS Trust, London, UK.
  • Ademokun D; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Tholouli E; Ipswich Hospital NHS Trust, Ipswich, UK.
  • Andrews VE; Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
  • Jenner M; Medway Maritime Hospital, Kent, UK.
  • Parrish C; University Hospital Southampton NHS Foundation, Southampton, UK.
  • Yong K; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Cavet J; Department of Haematology, University College Hospital, London, UK.
  • Hunter H; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
  • Bird JM; Department of Haematology, Plymouth Hospitals Trust, Plymouth, UK.
  • Pratt G; Department of Haematology, University Hospitals Bristol NHS Trust, Bristol, UK.
  • Drayson MT; Department of Haematology, Heart of England NHS Trust, Birmingham, UK.
  • Brown JM; University of Birmingham, Birmingham, UK.
  • Morris TCM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Br J Haematol ; 185(3): 450-467, 2019 05.
Article em En | MEDLINE | ID: mdl-30729512
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido